NO20063374L - Fremgangsmate for fremstilling av tumornekrosefaktor-proteinbindinger - Google Patents

Fremgangsmate for fremstilling av tumornekrosefaktor-proteinbindinger

Info

Publication number
NO20063374L
NO20063374L NO20063374A NO20063374A NO20063374L NO 20063374 L NO20063374 L NO 20063374L NO 20063374 A NO20063374 A NO 20063374A NO 20063374 A NO20063374 A NO 20063374A NO 20063374 L NO20063374 L NO 20063374L
Authority
NO
Norway
Prior art keywords
necrosis factor
tumor necrosis
preparation
protein binding
factor protein
Prior art date
Application number
NO20063374A
Other languages
English (en)
Inventor
Yolande Rouiller
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20063374L publication Critical patent/NO20063374L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oppfinnelsen angår fremgangsmåte for å øke den rekombinante produksjon av polypeptider, i særdeleshet tumornekrose faktorbindende proteiner, fra pattedyrceller ved en temperatur under 30ºC.
NO20063374A 2003-12-23 2006-07-20 Fremgangsmate for fremstilling av tumornekrosefaktor-proteinbindinger NO20063374L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03104958 2003-12-23
PCT/EP2004/053642 WO2005063813A2 (en) 2003-12-23 2004-12-21 Process for the production of tumor necrosis factor-binding proteins

Publications (1)

Publication Number Publication Date
NO20063374L true NO20063374L (no) 2006-09-18

Family

ID=34717253

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063374A NO20063374L (no) 2003-12-23 2006-07-20 Fremgangsmate for fremstilling av tumornekrosefaktor-proteinbindinger

Country Status (8)

Country Link
US (1) US20070099266A1 (no)
EP (1) EP1697414A2 (no)
JP (1) JP2008504009A (no)
AU (1) AU2004309114A1 (no)
CA (1) CA2548940A1 (no)
IL (1) IL176326A0 (no)
NO (1) NO20063374L (no)
WO (1) WO2005063813A2 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI456062B (zh) 2006-09-13 2014-10-11 Abbvie Inc 細胞培養改良
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
WO2014143205A1 (en) 2013-03-12 2014-09-18 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705364A (en) * 1995-06-06 1998-01-06 Genentech, Inc. Mammalian cell culture process
TR200504220T2 (tr) * 1998-12-17 2007-04-24 Biogen Idec Ma Inc. Aktif limfotoksin-beta reseptör imunoglobülin şimeAktif limfotoksin-beta reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştrik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.ırılması için bir yöntem.
AU3881100A (en) * 1999-03-15 2000-10-04 Human Genome Sciences, Inc. Human tumor necrosis factor receptor-like genes
WO2003046160A2 (en) * 2001-11-30 2003-06-05 Applied Research Systems Ars Holding N.V. Methods of increasing protein expression levels
EP1497444B1 (en) * 2002-03-27 2015-11-04 Immunex Corporation Methods for increasing polypeptide production
MXPA05006523A (es) * 2002-12-23 2005-08-26 Squibb Bristol Myers Co Procesos de cultivo de celulas de mamiferos para la produccion de proteinas.

Also Published As

Publication number Publication date
CA2548940A1 (en) 2005-07-14
WO2005063813A3 (en) 2005-10-27
US20070099266A1 (en) 2007-05-03
AU2004309114A1 (en) 2005-07-14
WO2005063813A2 (en) 2005-07-14
EP1697414A2 (en) 2006-09-06
IL176326A0 (en) 2006-10-05
JP2008504009A (ja) 2008-02-14

Similar Documents

Publication Publication Date Title
NO20063374L (no) Fremgangsmate for fremstilling av tumornekrosefaktor-proteinbindinger
WO2007002261A3 (en) IL-1β BINDING ANTIBODIES AND FRAGMENTS THEREOF
UA97473C2 (ru) Выделенное антитело, которое связывается с her-3, и его применение
ES2379283T3 (es) Proteínas de unión a albúmina sérica
ATE519847T1 (de) Il-17-homologe polypeptide und ihre therapeutische verwendung
WO2006042158A3 (en) Methods and compositions for improving recombinant protein production
MX2010005966A (es) Conjugados de anticuerpo monoclonal-molecula asociada dirigidos a la proteina tirosina-cinasa 7 (ptk7).
WO2003104418A3 (en) RECONSTITUTED POLYPEPTIDES
WO2002095010A3 (en) Human secreted proteins
WO2001055364A3 (en) Nucleic acids, proteins, and antibodies
MX2012005864A (es) Proteinas de enlace al antígeno anti-orai 1 y usos de las mismas.
EA200901436A1 (ru) Антигенсвязывающие белки, связывающие par-2
UA97516C2 (ru) Полностью человеческое моноклональное антитело против vap-1
WO2006073976A3 (en) Compositions, methods, and kits for enhancing protein expression, solubility and isolation
JO2991B1 (ar) بروتينات رابطة لمولد ضد المستقبل ايه للانترليوكين 17
WO2010007144A3 (en) Mutated netrin-4 proteins, fragments thereof and their uses as drugs
MX2021015698A (es) Integración dirigida de configuraciones aleatorias de ácidos nucleicos.
ATE466874T1 (de) Mit scytovirin der domäne 1 verwandte polypeptide
EP1576157A4 (en) FLUORESCENCE PROTEINS FROM COPEPODA SPECIES AND METHOD FOR USE THEREOF
NZ589806A (en) Variant hedgehog-interacting protein (hhip1) and methods and uses thereof
ATE320484T1 (de) Histone-deacetylase-8 proteine, nukleinsäuren und methoden zur verwendung
DE60235985D1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
WO2001064913A3 (en) Cell cycle proteins associated with rad9, compositions and methods of use
WO2002061049A3 (en) Novel molecules of the pyrin/nbs/lrr protein family and uses thereof
DE602005018369D1 (de) Neue proteine, z.b. zur verwendung für die in-vitro-isolierung und prävention von legionella pneumophila-infektionen

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA, 0125 OSLO, NO

FC2A Withdrawal, rejection or dismissal of laid open patent application